Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab

Ophthalmologica. 2018;239(4):240. doi: 10.1159/000481178. Epub 2018 Jan 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Genetic Predisposition to Disease*
  • Humans
  • Intravitreal Injections
  • Ranibizumab / administration & dosage*
  • Risk Factors
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Wet Macular Degeneration / drug therapy*
  • Wet Macular Degeneration / genetics

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A
  • Ranibizumab